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BACKGROUND: Despite evidence of the importance of cervical cancer screening, screening rates in the United States
remain below national prevention goals. Women in the Appalachia Ohio region have higher cervical cancer incidence
and mortality rates along with lower cancer screening rates. This study explored the expectations of Appalachian
Ohio women with regard to Papanicolaou (Pap) test cost and perceptions of cost as a barrier to screening. METH-
ODS: Face-to-face interviews were conducted with 571 women who were part of a multilevel, observational commu-
nity-based research program in Appalachia Ohio. Eligible women were identified through 14 participating health
clinics and asked questions regarding Pap test cost and perceptions of cost as a barrier to screening. Estimates of
medical costs were compared with actual costs reported by clinics. RESULTS: When asked about how much a Pap
test would cost, 80% of the women reported they did not know. Among women who reportedly believed they knew
the cost, 40% overestimated test cost. Women who noted cost as a barrier were twice as likely to not receive a test
within screening guidelines as those who did not perceive a cost barrier. Furthermore, uninsured women were more
than 8.5 times as likely to note cost as a barrier than women with private insurance. CONCLUSIONS: Although under-
served women in need of cancer screening commonly report cost as a barrier, the findings of the current study sug-
gest that women may have a very limited and often inaccurate understanding concerning Pap test cost. Providing
women with this information may help reduce the impact of this barrier to screening. Cancer 2010;116:4727–34.
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Despite efforts to improve screening rates, Papanicolaou (Pap) test rates remain below the national prevention goal
that 90% of women aged 18 years should have received a Pap test within the past 3 years.1 In general, screening has
proved a particularly important tool for reducing the impact of certain cancers, especially for slow-growing, preventable
cancers such as cervical cancer.2,3 Nevertheless, data from the 2005 National Health Interview Survey indicated that 1 in 5
women (20%) did not receive a Pap test within the past 3 years.4 Given estimates that 11,270 new cases of invasive cervical
cancer and 4070 deaths would occur in 2009,5 the importance of improving screening rates to improve women’s survival
rates through early detection cannot be underestimated.
In the Appalachia Ohio region of the United States, an area characterized by lower income, higher unemployment
rates, and lower levels of education,6-8 recent research has shown both greater cancer incidence and mortality rates, along
with a lower prevalence of cancer screening behaviors.9 Cervical cancer incidence rates reported in 2006 were found to be
37% higher among women in Appalachia Ohio compared with women from non-Appalachia Ohio, and mortality rates
from cervical cancer were 44% higher for women from Appalachia Ohio compared with their non-Appalachia Ohio coun-
terparts.9 Rates of receipt of a Pap smear within the past 3 years demonstrated similar differences, with women from Appa-
lachia Ohio having a rate that was 9% lower than women from non-Appalachia Ohio.9
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Numerous barriers to a woman’s receipt of cervical
cancer screening have been identified, including the socio-
demographic factors of age, income, and education7,10-13;
behavioral factors such as understanding of screening ben-
efits, fear of cancer, and embarrassment10,13-15; and pro-
vider factors including physician perceptions15 and
practice characteristics.13,16 For women residing in Appa-
lachia Ohio, recent research has suggested that the factors
of cost, insurance coverage, and perceptions regarding the
test itself (eg, embarrassment, privacy issues) may be par-
ticularly salient barriers to cervical cancer screening.17 In
addition, prior research has explored the issues of cost and
insurance coverage in relation to other cancer screening
practices, including mammograms18,19 and colorectal
cancer screening tests.20 However, to the best of our
knowledge, no studies published to date have investigated
the importance of these barriers relative to cervical cancer
screening practices in this underserved population. This
research was designed to explore expectations about Pap
test cost and perceptions of cost as a barrier to cervical can-
cer screening among an underserved population of
women residing in Appalachia Ohio.
MATERIALS AND METHODS
Data Source
The data for this study were obtained from interviews
conducted between 2005 and 2006 as part of the Com-
munity Awareness Resources Education (CARE) project
‘‘Reducing Cervical Cancer in Appalachia’’ study, a multi-
level, observational community-based research program
designed to understand why high rates of cervical cancer
incidence and mortality are observed in Appalachia Ohio.
As part of this study, 22 health clinics were identified in
Appalachia Ohio, each of which performed >200 Pap
tests per month. Fourteen of those clinics agreed to partic-
ipate in the study; their patient rolls were randomly
sampled to identify women who might be eligible for the
study.
The survey instrument was designed to gather infor-
mation regarding the women’s demographics, sources of
medical care, knowledge and beliefs concerning cervical
cancer and Pap test screening, cost of the Pap test, and
health and sexual history. The cross-sectional survey was
ultimately completed, in face-to-face interviews, by 571
eligible women whose responses were used in these analy-
ses. A detailed study design and procedures have been
summarized previously.21 Informed consent procedures
and study protocols were reviewed and approved by the
Institutional Review Boards of the Ohio State University,
University of Michigan, and Centers for Disease Control
and Prevention.
Statistical Analysis
Descriptive statistics were calculated to describe study
population demographics and cervical cancer screening
history. Additional analyses were conducted to investigate
perceptions of Pap test cost as a barrier to care access. We
analyzed women’s perceptions of Pap test costs and com-
pared perceptions of Pap test medical costs with the actual
medical cost of cervical cancer screening for the study
population and with women’s actual Pap test use. We also
compared Pap test cost perceptions with the perceived
and actual risk of cervical cancer of the study participants.
All comparisons were tested using the Fisher exact test. A
mixed effects logistic regression model was used to explore
those factors associated with a woman’s propensity to state
that the cost of a Pap test was an obstacle for her. Explana-
tory variables in the model included age, insurance,
income, education, marital status, and level of worry
about cervical cancer. All the variables were either dichot-
omous or categoric. Random effect intercepts were com-
puted to account for correlations in the data at the level of
individual health clinics. Because of the lack of readily
available methods for mixed models with dichotomous
outcomes, the model fit and discrimination were calcu-
lated using the marginal model with clinic as a fixed effect
using the Hosmer-Lemeshow goodness-of-fit test and the
area under the receiver operating characteristic (ROC)
curve.22
All analyses were performed with SAS statistical soft-
ware (version 9.1; SAS Institute Inc, Cary, NC), STATA
software (version 10.0; StataCorp LP, College Station,
TX), and Microsoft Excel 2007 (Microsoft Corporation,
Redmond,WA).
Key Variables
Interviewers asked each woman about her health history
and demographics, her insurance coverage, and her per-
ception of Pap test costs. Several additional variables were
constructed from the survey data. The paragraphs that fol-
low describe how those variables were calculated.
Pap test cost perceptions
Respondents were asked 3 questions. They first were
asked ‘‘About how much does a Pap smear cost in your
community?’’ Valid responses were comprised of a dollar
figure or ‘‘I do not know.’’ Next, regardless of their
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response to the preceding question, each woman was
asked to select a cost category: ‘‘Would you expect it to
cost: not more than $10, $10 to $25, $26 to $50, $51 to
$75, $76 to $100, $101 to $150, or more than $150.’’
Valid responses included 1 of the categories above, or ‘‘I
do not know.’’ Later in the interview, women were asked
‘‘Does the cost of a Pap smear make it hard for you to get
one?’’ Valid responses included ‘‘Yes,’’ ‘‘No,’’ or ‘‘I do not
know.’’
Accuracy of cost estimate
For this study, each woman was classified with
regard to whether her perception of Pap test cost was accu-
rate. Her response to the cost category question (the sec-
ond question above) was used to gauge whether her cost
perception was in the ‘‘appropriate’’ range. The ‘‘appro-
priate’’ range was determined by polling participating
clinics regarding the cost of a Pap smear. The clinics’
answers ranged from $28 to $90. The relatively wide
range provides for a conservative estimate. However, to
assess accuracy, we compared this range with theMedicare
fee schedule for Ohio providers and found that provider
reimbursement at the time of the study was $38.45 for a
Pap test (according to the Centers for Medicare and Med-
icaid services). In the current analyses, we used the con-
servative range of costs, coding cost perception as
‘‘appropriate’’ if the estimate was between $26 and $100,
‘‘under’’ if the cost was <$26, or ‘‘over’’ if the response
was >$100. Women who responded ‘‘I do not know’’
comprised a fourth category.
Health insurance status
Respondents were asked about current health insur-
ance coverage. Possible responses included: 1) private in-
surance, either through someone’s job or purchased by the
respondent’s family; 2) primarily Medicaid; 3) primarily
Medicare; or 4) no insurance. Respondents could select
>1 source of health insurance.
Risk of cervical cancer
Respondents were classified as being at high risk if
they had ever been diagnosed with human immunodefi-
ciency virus, gonorrhea, genital herpes, syphilis, or vene-
real warts; or if they were a current smoker; ever had a
sexual partner with a sexually transmitted disease; were
aged <18 years the first time they had sexual intercourse;
or if their number of lifetime sexual partners was >4.
Otherwise, they were classified as being at low risk for cer-
vical cancer.
Perceived risk of cervical cancer
Participants were asked ‘‘How would you rate your
own risk of getting cervical cancer in the next 5 years,
compared with other women you know? Would you say
your risk is: much lower, somewhat lower, about the
same, somewhat higher, or much higher?’’ The responses
were collapsed into 4 categories: lower, about the same,
higher, and ‘‘I do not know.’’
Level of worry
Women were asked ‘‘How much do you worry
about getting cervical cancer?’’ Valid responses were ‘‘A
lot,’’ ‘‘Some,’’ and ‘‘Not at all.’’
Pap test within guidelines
If the respondent was at low risk for developing
cervical cancer, she was then considered to be within
Pap test guidelines if she had received a Pap test any
time within the 3 years preceding the interview. If she
was at high risk for cervical cancer, then she was consid-
ered to be within guidelines if she had received a Pap
test within the year leading up to the interview. Other-
wise, she was classified as not having received a Pap test
within guidelines.
RESULTS
Characteristics of the Study Population
The study population (n¼ 571) reflects the population of
Appalachia Ohio, a group that is predominantly white
and includes many low-income residents. Table 1 presents
the demographic and Pap test history characteristics of
this sample. Across study participants, nearly all (95%)
were white, and greater than half (56%) reported an an-
nual household income below 200% of the federal pov-
erty level; approximately one-third (34%) reported an
annual household income of <$20,000. Approximately
56% of the respondents were privately insured whereas
24% reported Medicaid coverage and 15% were unin-
sured. Less than 5% of women in this sample were cov-
ered byMedicare.
Among respondents, nearly one-quarter (24%)
reported that they had been without health insurance cover-
age at some time during the last 12 months. In addition,
almost 1 in 5 women (19%) noted that during the last 12
months there was a time during which they needed health-
care but did not get it because they could not afford it.
The majority (66%) of participants reported that
their physician did not encourage them to undergo a Pap
Pap Cost Perceptions in Appalachia Ohio/McAlearney et al
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test. Furthermore, although 35% of participants reported
an abnormal Pap test result in the past, only 68% of
respondents had received a Pap test within guidelines.
Perceptions of Cost as a Barrier and Receipt
of a Pap Test Within Guidelines
Nearly 1 in 5 participants (18%) reported that the cost of
a Pap test made it difficult for them to get the test. Among
women who had not received a Pap test within the past 3
years and who gave a specific reason for not getting
screened (n ¼ 34), approximately one-third (29%)
reported cost as the reason, and 18% stated that their in-
surance does not cover the test. Furthermore, women who
stated that the cost of a Pap test made it difficult to get
were significantly more likely to not receive a Pap test
within guidelines (odds ratio [OR], 2.09; 95% confidence
interval [95% CI], 1.31-3.33 [P ¼ .002]). Receipt of a
Pap test once every 3 years for low-risk women and once
per year for high-risk women was considered to be within
screening guidelines.
Of participating women who had not received a Pap
test within guidelines (n ¼ 183), only 22% reported hav-
ing heard of any program to help pay for the test. Only
14% had heard of the Breast and Cervical Cancer Control
Program (BCCCP), the reduced cost program designed
to help women afford screening tests for breast and cervi-
cal cancer. Of the total study sample (n ¼ 571), only 7
women (1.2%) reported having received a Pap test that
was paid for with BCCCP funding.
Pap Test Cost Expectations
When asked, ‘‘About how much does a Pap smear cost in
your community?’’ the great majority of study partici-
pants responded ‘‘I do not know’’ (81%) (Table 2). The
remaining 106 women provided numerical responses to
the question (ie, gave a dollar value). Expectations of Pap
test cost for study participants are summarized in Table 2.
Among these respondents, the highest dollar figure
reported was $400, and the lowest was $0. As noted ear-
lier, at the time these interviews were conducted, the
actual cost of a Pap test in these communities ranged from
$28 to $90. Thus, approximately 42% of responding
women overestimated the cost of a Pap test by at least
$10, and nearly 1 in 5 overestimated the cost by at least
$60.
In response to the second question regarding cost,
women provided estimates in different cost categories
(Table 2). When presented with potential cost categories,
more women were willing to estimate Pap test cost (ie,
Table 1. Demographic Characteristics and Pap Test History of










Black or African American 17 (3%)
Other 14 (2%)









Private only 315 (56%)
Medicaid 137 (24%)
Medicare 28 (5%)
No insurance 86 (15%)
Education
High school 46 (8%)
High school graduate/GED 206 (36%)
Some college/college graduate 319 (56%)
Working status
Full time, part time, or self-employed 378 (66%)




Not married 222 (39%)
Married or member of a couple 349 (61%)
Pap Test History
Physician encouraged a Pap test
No 377 (66%)
Yes 193 (34%)
History of an abnormal Pap test
No 370 (65%)
Yes 197 (35%)
Pap test within guidelines
No 182 (32%)
Yes 380 (68%)
At high risk for cervical cancer
No 117 (21%)
Yes 441 (79%)
Worry about getting cervical cancer
A lot 38 (7%)
Some 185 (32%)
Not at all 347 (61%)
Pap indicates Papanicolaou; GED, General Equivalency Diploma.
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only 9% of respondents reported ‘‘I do not know’’), but
similar proportions overestimated the test cost (38% over-
estimated by at least $10 and 15% overestimated by at
least $60).
Accuracy of Pap Test Cost Perceptions
The accuracy of perceptions regarding Pap test cost was
compared between women who were initially willing to
provide a numeric cost estimate in dollars (n ¼ 106) and
women who were unable to estimate or answered that
they did not know (n ¼ 464). The first question was used
only to categorize whether the women were willing to pro-
vide an unaided cost estimate; the cost estimates that were
compared between groups were the categoric responses to
the second cost question. The accuracy of Pap test cost
estimates was then categorized as ‘‘appropriate,’’ ‘‘under,’’
‘‘over,’’ and ‘‘do not know’’ (Fig. 1).
Women in both groups were more likely to overesti-
mate than underestimate the cost of a Pap test. Women
who provided a numeric cost estimate initially were more
likely to appropriately estimate the Pap test cost compared
with those who initially did not know the cost of a Pap
test. In addition, women who responded ‘‘I do not know’’
to the first question were more likely to overestimate the
cost of a Pap test in the follow-up categoric question than
women who provided a numeric response (40% vs 30%;
P¼ .064). Women who stated ‘‘I do not know’’ were also
less likely to underestimate the cost of a Pap test (3% vs
9%, respectively; P¼ .016).
Perception of Cost as a Barrier to a Pap Test
Insurance status, income, and educational attainment
were found to be significantly related to stating that the
cost of a Pap test makes it difficult to get one, with insur-
ance status appearing to have the strongest association.
Table 3 lists the adjusted ORs and associated 95% CIs for
the main effects in the logistic regression model. The odds
of a woman with no insurance stating that cost makes it
difficult to get a Pap test were 8.66 times those of a
woman with private insurance (95% CI, 4.20-17.82).
Conversely, for a woman with Medicaid coverage, the
odds of stating that cost was an obstacle were 0.35 times
those of a woman with private insurance (95% CI, 0.15-
0.80).
The odds of a woman whose income was below
200% of the federal poverty level stating that cost was a
Table 2. Pap Test Cost Expectations
How Much Respondents Expected a Pap Test to
Cost, With No Guidance About Cost Categories
(n5571)
Response (n5571) No. of Respondents
Gave dollar value response 106 (19%)







How Much Respondents Expected a Pap Test to
Cost, by Cost Category Provided (n¼571)
Cost Category No. of Respondents







Do not know 51 (9%)
Pap indicates Papanicolaou.
Figure 1. Distribution of the accuracy of Ohio Appalachia
women’s perceptions of the cost of the Papanicolaou (Pap)
test is shown by initial willingness to estimate Pap test cost
(n ¼ 570). The chi-square test was performed for overall in-
dependence (P ¼ .001) and for the ‘‘overestimate’’ category
only (P ¼ .064). Diagonal striped bars indicate do not know;
dark bars, overestimate; light bars, appropriate estimate; hor-
izontal striped bars, underestimate.
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barrier were 2.17 times higher than those of a woman
with an income above 200% of the federal poverty level
(95% CI, 1.11-4.23). Furthermore, women with less edu-
cation had higher odds of stating that the cost of a Pap test
makes it difficult to get. Women who completed high
school had odds of responding that cost is an obstacle that
were 1.79 times higher than women who had been to col-
lege (95%CI, 1.01-3.19).Women who failed to complete
high school had odds of reporting cost as an obstacle that
were 2.49 times those of college-educated women (95%
CI, 0.95-6.54).
The Hosmer-Lemeshow goodness-of-fit test indi-
cated that the model fit the data reasonably well; the test
failed to reject the null hypothesis of good fit (P¼ .7984).
Furthermore, the model was found to have good predic-
tive power; the area under the ROC curve was 85%.
Risk Knowledge and Cost Factors
Overall, 440 women (79%) were found to be at high risk
for cervical cancer based on their sexual and medical his-
tories and smoking status. Women at high risk for cervical
cancer were compared with those at low risk by compar-
ing the percentage in each group who stated that the cost
of a Pap smear makes it hard for them to receive it. It is
interesting to note that women at high risk were more
likely to state that the cost makes it difficult for them to
get a Pap test than women at low risk (20% vs 12%; P ¼
.058). Yet these women were not always aware of their
high-risk status. Among women who were found to be at
high risk of developing cervical cancer, 54% reported that
they perceived their risk as being the same as that of other
women they knew, 22% reported their risk as being
higher, and 20% reported their risk as being lower. In
contrast, among women who were found to be at low risk
of developing cervical cancer, 52% reported that they per-
ceived their risk as being the same as that of other women
they knew, 6% reported their risk as being higher, and
38% reported their risk as being lower. Table 4 shows
these comparative proportions based on risk.
DISCUSSION
Underserved women in need of an important cancer screen-
ing test commonly report cost as a barrier to screening as
well as to the receipt of needed medical care. However, the
findings of the current study suggest that women in Appala-
chia Ohio have a very limited and often inaccurate under-
standing of the cost of cervical cancer screening. Women in
the current study either reported no knowledge of Pap test
cost or tended to overestimate the cost. Specifically, we
found that 4 in 5 women reported having no knowledge of
the actual cost of a Pap test. Moreover, approximately 42%
of women who believed they had knowledge of the cost of a
Pap test overestimated the cost by at least $10, with nearly 1
in 5 overestimating the cost by >$60. If less conservative
estimates concerning the actual medical cost of a Pap test as
Table 3. Associations Between Independent Variables and
Stating Cost Makes It Difficult to Obtain a Pap Test (n¼571)
Adjusted OR 95% CI
Insurance coverage
Private only 1.00 —
Medicaid 0.35a 0.15-0.80
Medicare 0.28 0.05-1.49






‡200% of federal poverty line 1.00 —
<200% of federal poverty line 2.17b 1.11-4.23
Education
Some college or college graduate 1.00 —
High school or GED 1.79b 1.01-3.19
Less than high school 2.49 0.95-6.54
Marital status
Married or member of a couple 1.00 —
Not a member of a couple 1.56 0.88-2.77
Worry about cervical cancer
Not at all 1.00 —
Some 1.32 0.73-2.37
A lot 0.90 0.31-2.64
Pap indicates Papanicolaou; OR, odds ratio; 95% CI, 95% confidence
interval; GED, General Equivalency Diploma.
aP  .01.
bP . 06.
Table 4. Perceived Cervical Cancer Risk Versus Risk










Low Risk High Risk
Do not know 5 (4%) 20 (5%)
Lower 44 (38%) 88 (20%)
About the same 61 (52%) 237 (54%)
Higher 7 (6%) 95 (22%)
Total 117 440
aChi-square test for overall independence: P ¼ .0001.
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reported by Medicare were used, these overestimates and
the percentage of women who overestimated Pap test cost
would be even greater.
Although the current study findings are consistent
with previous research demonstrating cost as a barrier to
preventive screenings,17-20 these results suggest that a lack of
knowledge regarding the actual cost of Pap tests may mag-
nify the perception of cost as a barrier.Women who initially
report not knowing the cost of a Pap test were more likely to
overestimate the cost when pressed for an answer.
Perceptions of cost as a barrier have also been asso-
ciated with lack of insurance, a lower income level, and
lower educational attainment, and the results of the cur-
rent study are consistent with those reported in the litera-
ture. For example, a lack of health insurance is often
cited as a major barrier to all types of healthcare serv-
ices.23,24 Not surprisingly, women in the current study
who lacked insurance were >8.5 times more likely to
report cost as a barrier to receiving a Pap test compared
with those with private insurance. This finding is in
keeping with previous research that has demonstrated
that costs and lack of insurance are barriers to access for
preventive screenings among vulnerable popula-
tions.10,25,26 We found that the perception of cost as a
barrier among these vulnerable women from Appalachia
Ohio was related to lower use of cervical screening tests.
Women in the current study who believed that the cost
of a Pap test makes it difficult to receive one were twice
as likely not to receive a Pap test within screening guide-
lines compared with those women who did not view cost
as a barrier to receiving the test.
Another important consideration highlighted by the
findings of the current study is that of the relation
between risk status and cost as a barrier to receiving a Pap
test. Although high-risk women were more likely to state
that cost makes it difficult for them to receive a Pap test, it
was also clear that many of these women were not aware
of their actual risk status. Instead, 20% of women who
were high risk reported perceiving themselves to be at
lower risk than other women they knew. Given the inac-
curacies in perceptions regarding both risk status and cost
as a barrier, these findings are of great concern.
The current study has limitations associated with
both the population studied and the questions asked in
the survey. First, this cross-sectional study was limited to
the population of Ohio Appalachia, an area characterized
by high levels of poverty and lower levels of educational
attainment. Although this sample included women from
both urban and rural counties and may be generalized
across other similarly underserved areas of the United
States, certain demographic features of this population,
such as a low proportion of minority residents, may dis-
tinguish these results.
Another limitation can be attributed to the study
design itself, stemming from the fact that all the women
interviewed were linked to a clinic participating in the study.
Because this linkage provides evidence that all participating
women had had clinic contact and thus access to care within
the past 2 years, it is likely that the results of the current
study are more favorable than they might have been if the
study population also included women not affiliated with
health clinics. Thus, given our findings concerning the gen-
eral lack of knowledge regarding Pap test costs and cost as a
barrier to receiving Pap tests, it is likely that the level of
knowledge among women who were not affiliated with a
medical clinical might have been even lower.
Finally, the current study only considered women’s
perceptions of the direct medical costs of a Pap test. Other
costs associated with the Pap test, such as transportation,
child care, and unpaid time off, are also important cost
considerations that may affect women’s perceptions con-
cerning the overall cost of a Pap test. Therefore, the cur-
rent study results may underestimate the impact of cost as
a barrier to Pap tests.
Conclusions
Given the potential for women’s perceptions to influence
their motivation to seek cancer screening, addressing this
knowledge barrier regarding Pap test cost is likely impor-
tant. Efforts to increase Pap test use and reduce cervical
cancer incidence could focus on this specific population
to increase awareness about Pap test costs, improve
knowledge regarding cancer risk, increase Pap test receipt,
and ultimately reduce the disproportionate burden of dis-
ease experienced among underserved women.
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